Drug intelligence / Profile preview

geranium oil

Development stage
Preclinical
Lead developer
Northwest Life Science Specialties
Modality
Small Molecules
Administration
Topical, Inhalation, Oral
01

Overview

Geranium oil is an essential oil primarily derived from the plant *Pelargonium graveolens*. It is a complex mixture of bioactive small molecules, with major constituents typically including citronellol, geraniol, and linalool. The oil is investigated for a variety of clinical applications, most notably the topical treatment of neuropathic pain and numbness, where it is thought to provide analgesic relief. It also exhibits significant anti-inflammatory, antioxidant, and antimicrobial properties. Research suggests it may inhibit the secretion of pro-inflammatory cytokines and reduce microglial activation, offering potential neuroprotective benefits in models of Parkinson's disease. Geranium oil is categorized by the FDA as Generally Recognized as Safe (GRAS) and is utilized in diverse delivery systems, including nanoemulsions, hydrogels, and niosomes, to improve its stability and therapeutic efficacy.

Other names
rose geranium oilPelargonium graveolens oilgeranium essential oilBourbon geranium oil
02

Targets

IL-6 (Interleukin 6)NF-κBTNFA (Tumor necrosis factor alpha (soluble))CASP1 (Caspase-1)

Beyond the preview

Go deeper on geranium oil.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on geranium oil.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call